ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
6.85
+0.08 (1.18%)
At close: Jan 8, 2026, 4:00 PM EST
6.85
0.00 (0.00%)
After-hours: Jan 8, 2026, 4:04 PM EST
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $72.96 million as of January 8, 2026.
Market Cap
72.96M
Enterprise Value
-65.33M
1-Year Change
n/a
Ranking
Category
Stock Price
$6.85
Market Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $174.36M to $72.96M, a decrease of -58.16%. That is a compound annual growth rate of -85.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 72.11M | -1.88% |
| Dec 31, 2025 | 73.49M | -57.85% |
| Jul 28, 2025 | 174.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 986.15B |
| Johnson & Johnson | 498.72B |
| AbbVie | 396.97B |
| UnitedHealth Group | 313.17B |
| AstraZeneca | 297.23B |
| Merck & Co. | 275.28B |
| Novartis AG | 273.49B |
| Novo Nordisk | 254.60B |